Estimating Relative Survival of Breast Cancer Patients Referring to Imam Khomeini Cancer Institute during 1990-95
DOI:
https://doi.org/10.22100/jkh.v4i3.178Keywords:
Net survival, Relative Survival, Cause-specific Survival, Breast CancerAbstract
Introduction: In comparison with observed and cause-specific survival, relative survival, as an estimate of net survival, has become a more preferred measure for the analysis of patients’ survival based on data from population-based-cancer registries. This research is carried out to estimate and investigate the net survival of breast cancer patients.
Methods: In order to estimate relative survival, we used Finnish annual probabilities of death as a standard source to estimate expected survival in this study. Data consist of 662 breast cancer patients diagnosed at the cancer institute of Imam Khomeini hospital during 1990-95 and followed up to the end of 2000. Data were analyzed using SAS software, version 9.1.
Results: The results showed that the three-year relative survival for 3 age groups of 15-44, 45-59 and 60-74 were 85, 90 and 80% respectively, whereas it was low for the age group of 75+ (67%). Following up the age group of 45-59 for two consequent years, the estimate of relative survival ratio was obtained approximately one. For some intervals, the follow-up estimate of relative survival was greater than one.
Conclusion: Based on the results, survival following diagnosis of cancer has decreased with the increasing of age groups. It is also seen that, with the increasing years of follow-up, survival following diagnosis of cancer has first decreased and then a little increased. The decreasing rate for age group of 75+ is noticeable. The statistical cure point for the age group of 45-59 is acceptable but for the age groups of 45-59 and 60-74, the quality of following up is low in some follow-up intervals.
References
Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101-121.
Esteve J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med 1990;9(5):529-38.
Heinavaara S, Hakulinen T. Relative Survival of patients Subsequent Cancer. J Cancer Epidemiol Prev 2002;7(4):173-9.
Percy CL, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981;71(3):242-250.
Erhardt CL. What is the cause of death? JAMA 1958;168:161-168.
Bell CMJ, Lawrence G, Pheby DFH, Smith J, Coleman MP. The role of cancer registries. Clinical Oncology 1995;7(3):143-144.
Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10. Bathseda, MD: End Results Evaluation Section, National Cancer Institute;1959.
Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38(4):933-942.
Berkson J, Gage RP. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin 1950;25(11):270-286.
Coleman MP, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, et al. Cancer survival trends in England and Wales 1971-1995: deprivation and NHS region. Series SMPS No. 61 London: The Stationery Office;1999.p.1-695.
Cutler SJ, Axtell LM. Partitioning of a patient population with respect to different mortality patterns. Journal of the American Statistical Association 1963;58:701-712.
Kerr GP, Kunkler IH, Langlands AO, Rodger A. (In)curability of breast cancer: a 30-year report of a series of 3933 patients. Breast, 1998;7(2):90-94.
Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, et al. Eurocare-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14(5):128-149.
Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: Survival of cancer patients diagnosed 1990-94-- results and commentary. Ann Oncol 2003;14(5):61-118.
Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9(8):730-56.
Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8(9):773-783.
Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4: Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45(6):931-991.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
